According to a new market report published by Lucintel, the future of the cloud computing in cell biology, genomics, and drug development market looks promising with opportunities in the discovery & preclinical research, clinical trials, pharma manufacturing, commercialization, and plant & microbial gene analyses applications. The global cloud computing in cell biology, genomics, and drug development market is expected to grow with a CAGR of 23% from 2020 to 2025. The major drivers for this market are rising research activities related to genomics, increasing prevalence of cancer, and growing focus on genomics for drug discovery.
To download report brochure, please go to https://www.lucintel.com/cloud-computing-in-cell-biology,-genomic,-and-drug-development-market.aspx and click "download brochure" tab from the menu
In this market, discovery & preclinical research, clinical trials, pharma manufacturing, commercialization, and plant & microbial gene analyses are the major applications. Lucintel forecasts that discovery & preclinical research will remain the largest segment over the forecast period due to rising demand for genomics and increasing cancer diagnosis.
Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to increasing usage of genomics for research and development of new drugs and increasing prevalance of cancer.
North America will remain the largest region over the forecast period due to increasing investment in research activities related to genomics, rising prevalance of chronic diseases, and presence of advanced healthcare infrastructure in the region.
Google, Amazon Web Services, IBM, Oracle, Microsoft, Cisco Systems, DXC Technology, Salesforce, and SAP are among the major suppliers in the global cloud computing in cell biology, genomics, and drug development market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global cloud computing in cell biology, genomics, and drug development market by branch of biology, development type, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Cloud Computing in Cell Biology, Genomics, and Drug Development Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global cloud computing in cell biology, genomics, and drug development market by branch of biology, development type, application, end user, and region as follows:
By Branch of Biology [Value ($ Million) shipment analysis for 2014 – 2025]:
Plant Biology
Animal Biology
Human Biology
Microbiology
By Development Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Public Cloud
Private Cloud
Hybrid Cloud
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Discovery and Preclinical Research
Genomics
Diagnostics
Others
Clinical Trials
Pharma Manufacturing
Commercialization
Plant and Microbial Gene Analyses
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Clinical Laboratories
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.